Dr. S Bhattacharjee is a senior radiation oncologist at HCG Cancer Centre, Bengaluru, and he specialises in administering cobalt therapy, 3DCRT, IMRT, IGRT, TomoTherapy, CyberKnife, Brachytherapy, etc.
He is also skilled in administering chemotherapy for a broad spectrum of cancers. He has treated around 60,000 patients with chemotherapy during his 10-year stint at Thakurpukur Cancer Hospital, Kolkata.
In the last 12 years, he has treated more than 400 patients with CyberKnife.
In 2004, he discovered an immunomodifier - "Immuvac", which supports the treatment of immuno-compromised health conditions, such as AIDS, leprosy and cancers. This immuno-modifier was approved by USFDA in 2006, and is widely used throughout the USA.
He has collaborated with scientists to produce several drugs for the 1st time in the world in Cadila Pharmaceuticals Ltd, Ahmedabad.
He has published several papers in national and international journals, especially in ASTRO, ESMO, INTERNATIONAL NEURO SYMPOSIUM, etc.
Dr. Bhattacharjee has delivered lectures on scientific research in medical colleges of Kolkata, Chennai, Assam, RCC Trivandrum, Indian Institute of Toxicology, Lucknow, Indian Institute of Virology, Pune, Cancer Hospital in Dhaka, Bangladesh, etc.
He has conducted around 100 cancer awareness camps in West Bengal, Assam, Bihar, Orissa, Karnataka, etc.
He treated several thousand national and international cancer patients.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.